Project Grant R01MH138495

Award Date 12/1/24
Completion Date 11/30/29
Dollars Obligated $800K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
This $1,411,593 Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) supports research to elucidate the cellular and molecular functions of a human-specific neural enhancer called "HAR123." The research aims to determine how HAR123 differs between humans, chimpanzees, and mice in its impact on neural progenitor cell generation and cognitive flexibility. The 5-year project, awarded to the University of California, San Diego, will...
This Project Grant award from the National Institute of Mental Health (NIMH) under CFDA 93.242 - Mental Health Research Grants provides $2,694,945 in funding to the Lieber Institute for Brain Development to conduct research on understanding the cellular and circuit function of human-induced pluripotent stem cell (hiPSC) models in relation to the complex and heterogeneous genetic risk factors and clinical/cognitive phenotypes of schizophrenia. The research aims to: 1) replicate and expand on...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $295,768 to The Washington University in St. Louis to conduct research on the evolutionary expansion of the human cerebral cortex. The research aims to generate more accurate maps of cortical expansion between humans and macaques, and to investigate the transcriptional signatures underlying this expansion and the emergence of new cortical areas....
This $718,662 Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports research to characterize the genetic regulation of alternative polyadenylation (APA) in the developing human brain and its contribution to neuropsychiatric disorders like autism spectrum disorder (ASD) and schizophrenia (SCZ). The project aims to generate a comprehensive atlas of APA regulation across neurodevelopment, leveraging data from...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, provides $679,072 to President and Fellows of Harvard College to establish a platform that can accurately recapitulate and perturb cortical development and morphogenesis in vitro. The goal is to develop novel technologies that can reproduce key features of human forebrain development, including patterning, morphology, and regional cellular organization, and...
This Project Grant award from the National Institute of Mental Health (NIMH), under CFDA Program 93.242 Mental Health Research Grants, will support the development of novel tools to enable researchers to better understand the link between brain structure and function. The $323,978 award to the Child Mind Institute Inc., a non-profit research organization based in New York, will fund three key objectives: 1) extending a brain microstructure reconstruction tool called BrainBuilder to create...
This federal Project Grant award from the National Institutes of Health's (NIH) Trans-NIH Research Support program (CFDA 93.310) provides $1,389,728 to The Trustees of Princeton University to conduct research on the evolutionary development of the primate neocortex. The project aims to apply molecular tools and genomic analyses to the common marmoset, an emerging primate model, in order to reconstruct the lineage relationships, progenitor population demographics, and connectivity patterns across...
This $124,488 federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research to map cell type-specific isoform diversity in the human brain and dissect the mechanisms of alternative splicing in autism spectrum disorder (ASD). The project, led by Michael Margolis at the University of California, Los Angeles (UCLA), will leverage long-read sequencing technologies to fully characterize the brain's...
The National Institute of Mental Health (NIMH) awarded a $1,802,858 Project Grant (CFDA 93.242 Mental Health Research Grants) to the Scripps Research Institute in La Jolla, CA. The grant will fund research to map the functional impact of 72 high-confidence autism spectrum disorder and neurodevelopmental delay (ASD/NDD) risk genes using advanced in vivo genetic screening and whole-brain imaging technologies. This integrative approach aims to reveal how these genetic variants converge to produce...
This $2,576,654 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support the development of a cloud-based software platform and advanced computational pipelines to harmonize and integrate spatial transcriptomics data for the construction of a spatially resolved brain atlas. Key objectives of the 3-year project include: 1) Creating a cloud-based platform to standardize the analysis and visualization of...

This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $800,485 to Oregon Health & Science University (OHSU) to investigate the role of human-specific 3D genome conformation in brain development and disease.

The key research objectives are to: 1) analyze Hi-C data from cortical neural progenitor cells and neurons derived from human, chimpanzee, orangutan, and rhesus macaque to identify human-specific topologically associated domain (TAD) boundaries; 2) use computational tools to predict the effects of disrupting these human-specific TAD boundaries and prioritize 15 candidates for CRISPR-Cas9 editing in human iPSC-derived cells; and 3) introduce the 5 most effective human-specific TAD boundary deletions into chimpanzee iPSCs to create "humanized" cells for further molecular and physiological characterization.

This research aims to provide new insights into the mechanisms underlying human-specific brain development and vulnerability to neurodevelopmental disorders.

Generated 8/5/25, 5:00 AM